BRILINTA (Cardinal Health)
Welcome to the PulseAid listing for the BRILINTA drug offered from Cardinal Health. This P2Y12 Platelet Inhibitor [EPC],Phenylalanine Hydroxylase Activators [MoA],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cardinal Health |
| NON-PROPRIETARY NAME: | Ticagrelor |
| SUBSTANCE NAME: | TICAGRELOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | P2Y12 Platelet Inhibitor [EPC],Phenylalanine Hydroxylase Activators [MoA],Decreased Platelet Aggregation [PE],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A5 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2011-08-05 |
| END MARKETING DATE: | 0000-00-00 |
BRILINTA HUMAN PRESCRIPTION DRUG Details:
| Item Description | BRILINTA from Cardinal Health |
| LABELER NAME: | Cardinal Health |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 90(mg/1) |
| START MARKETING DATE: | 2011-08-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55154-9618_a0675665-555a-42c4-94d7-891c7c9742a8 |
| PRODUCT NDC: | 55154-9618 |
| APPLICATION NUMBER: | NDA022433 |
Other TICAGRELOR Pharmaceutical Manufacturers / Labelers:
